Urinary iodine concentration in adult patients with type 1 diabetes mellitus

Czech version

Authors: Michala Vosátková ¹; Denisa Janíčková Žďárská ²; Václav Zamrazil ¹; Martina Salátová ¹; Martin Hill ¹; Karel Vondra ¹
Authors‘ workplace: Endokrinologický ústav, Praha ¹; Interní klinika 2. LF UK a FN v Motole, Praha ²
Published in: Vnitř Lék 2016; 62(Suppl 3): 33-39
Category: Original Contributions

Overview

Introduction:
In patients with type 1 and 2 diabetes mellitus only rare data concerning the status of iodine supplementation and impact of possible iodine deficiency is available.

Aim:
To get basic information about (a) state of supply with iodine in patients with type 1 diabetes mellitus (DM1T), (b) the difference from non-diabetic population, (c) possible association of iodine saturation with some clinical and laboratory features of the diabetic syndrome, including the state of thyroid gland.

Subjects and methods:
We examined 54 men and 51 women treated with DM1T in a cross-sectional study. Age: median 42 years (25^th quartil 31, 75^th quartil 55), DM1T duration: 18 years (13, 23), BMI: 25.9 (23.3, 29.7), HbA_1c: 61 mmol/mol (51, 71), creatinine: 71 μmol/l (61, 83), micro-albuminuria 4.3 μg/min (1.9, 11.8), TSH: 1.77 mIU/l (1.12, 2.80). The iodine saturation was evaluated using iodine concentration in a sample of first morning urine.

Results:
Urinary iodine concentration in the whole group: median 152 μg/l, 25^th quartile 117 μg/l, 75^th quartile 219 μg/l. More than 50 % of the urinary iodine samples fell within range of optimal saturation (100–200 μg/l), 13 % within insufficient saturation (< 100 μg/l), 35 % of the samples showed increased saturation (> 200 μg/l), in which 2/3 were men. Using multiple regression analysis we found significant positive association of urinary iodine concentration and male gender, body weight, stature, and serum creatinine. No relation between urinary iodine and clinical and laboratory features of the diabetic syndrome was found.

Conclusions:
Iodine saturation in examined patients with DM1T was in accordance with ICCIDD (WHO) requirements for optimal/good saturation in non-diabetic population. With respect to the chosen normal urinary iodine concentration, eg. 100, resp. 150 μg/l the features of diabetic syndrome were not different. The question whether other factors than general measures taken in the past for solution of the iodine deficiency in the Czech Republic are involved in good level of iodine saturation in patients with DM1T should be addressed in further investigations comprising larger cohorts of patients.

Key words:
diabetes mellitus – urinary iodine concentration

Sources

1. Zamrazil V. Nemoci štítné žlázy v klinické praxi. Postgrad Med 2013; 15(7): 720–729.

2. Horáček J, Jiskra J, Límanová Z et al. Doporučení pro diagnostiku a léčbu onemocnění štítné žlázy v těhotenství a pro ženy s poruchou fertility. DMEV 2013; 16(1): 38–61.

3. Delange F, Bürgi H, Chen ZP et al. World status of monitoring iodine deficiency disorders control programs. Thyroid 2002; 12(10): 915–924.

4. Zamrazil V, Bílek R, Čeřovská J et al. Jodový deficit ve světě i v České republice – současný stav a perspektivy. Vnitř Lék 2010; 56(12): 1310–1315.

5. Niedobová E. Konečné výsledky kontroly zvýšené hladiny jódu v krmivech. In: Ryšavá L, Žoltá M. Sborník abstrakt 10. konference u příležitosti dne jódu. SZÚ Praha, dislokované pracoviště Karviná 2015: 30–32.

6. Zamrazil V, Čeřovská J. Jod a štítná žláza: optimální přívod jodu a poruchy z jeho nedostatku. Mladá fronta: Praha 2014: 12–22. ISBN 978–80–204–3302–2.

7. Triggiani V, Ciampollilo A, Guastamacchia E et al. Prospective study of post-partum thyroid immune dysfunctions in type 1 diabetic women and in a healthy control group living in a mild iodine deficient area. Immunopharmacol Immunotoxicol 2004; 26(2): 215–224.

8. Abalovich M, Amino N, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice quideline. J Clin Endocrinol Metab 2007; 92(8 Suppl): S1-S47.

9. Zamrazil V. Saturace jodem v České republice a ve světě – nedostatky a perspektivy. Kardiol Rev Int Med 2015; 17(2): 167–171.

10. Vondra K. Současný výskyt diabetes mellitus typu 1 a autoimunitní tyroiditidy – klinické aspekty. Čas Lék Čes 2012; 151(2): 73–75.

11. Vítková H, Anderlová K, Radiměřská V et al. Jodurie u těhotných žen s gestačním a pregestačním diabetem mellitem. In: Houdek L. Sborník abstrakt. 38. Endokrinologické dny, Špindlerův Mlýn. Galén: Praha 2015: 58.

12. Bílek R, Bednář J, Zamrazil V. Spectrophotometric determination of urinary iodine by the Sandell-Kolthoff reaction subsequent to dry alkaline ashing. Results from Czech Republic in the period 1994–2002. Clin Chem Lab Med 2005; 43(6): 573–580.

13. Dvořáková M, Bílek R, Čeřovská J et al. Volumy štítné žlázy u dospělé populace ve věku 18–65 let v České republice – Stanovení norem. Vnitř Lék 2006; 52(1): 57–63.

14. WHO, UNICEF, ICCIDD: Assessment of iodine deficiency disorders and monitoring their elimination. A guide for programme managers. Report of Consulation. May 4–6, Geneva: 1999.

15. Šilink K, Reisenauer R. Metabolic studies among the population of Bohemia and Moravia. 1. Nitrogen metabolism. 2. Relation of nitrogen to iodine in the population of Bohemia and Moravia in 1953. Čas Lék Čes 1957; 96(26): 809–812.

16. Zamrazil V, Bílek R, Čeřovská J et al. The elimination of iodine deficiency in the Czech Republic: the steps toward succes. Thyroid 2004; 14(1): 49–56.

17. Sullivan KM, Perrine CG, Pearce EN et al. Monitoring the iodine status of pregnant women in the United States. Thyroid 2013; 23(4): 520–521.

18. Okten A, Akcay S, Cakir M et al. Iodine status, thyroid function, thyroid volume and thyroid autoimmunity in patients with type 1 diabetes mellitus in an iodine-replete area. Diabetes Metab 2006; 32(4): 323–329.

19. Konrade I, Kalere I, Strele I et al. Iodine deficiency during pregnancy: a national cross-sectional survay in Latvia. Public Health Nutr 2015; 18(16): 2990–2997. Dostupné z DOI: <http://dx.doi.org/10.1017/S1368980015000464>.

20. Steiss JO, Otten A, Graef V et al. Thyroid gland ultrasound and urinary iodine excretion in children and adolescents with type I diabetes mellitus. Klin Pediatr 1996; 208(6): 327–333.

21. Vondra K, Vrbíková J, Bendlová B et al. Differences in type 1 diabetes mellitus of young adults with and without thyroid autoimmunity. Exp Clin Endocrinol Diabetes 2005; 113(7): 404–408.

22. Vondra K, Vrbíková J, Dvořáková K. Thyroid gland disease in adult patients with diabetes mellitus. Minerva Endocrinol 2005; 30(4): 217–236.